• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Advances in the psychosocial treatment of anxiety disorders. Implications for national health care.

作者信息

Barlow D H, Lehman C L

机构信息

Department of Psychology, Boston University, Mass., USA.

出版信息

Arch Gen Psychiatry. 1996 Aug;53(8):727-35. doi: 10.1001/archpsyc.1996.01830080079013.

DOI:10.1001/archpsyc.1996.01830080079013
PMID:8694686
Abstract

Recent developments in the psychosocial treatments for anxiety disorders suggest that we have reached an early plateau. Evidence now exists on the effectiveness of psychosocial treatment approaches for every anxiety disorder when compared with no treatment or credible psychosocial placebos. In many cases these procedures have limited clinical effectiveness and much remains to be learned about the disseminability and clinical utility of these approaches in the context of emerging national health care plans. We are just beginning the first generation of multisite studies examining the potentially synergistic effects of proven psychosocial treatments and proven drug treatments. These studies that have substantial significance for national health care are reviewed and some preliminary results are reported.

摘要

相似文献

1
Advances in the psychosocial treatment of anxiety disorders. Implications for national health care.
Arch Gen Psychiatry. 1996 Aug;53(8):727-35. doi: 10.1001/archpsyc.1996.01830080079013.
2
An update on treatment of the anxiety disorders.
Hosp Community Psychiatry. 1987 Aug;38(8):835-43. doi: 10.1176/ps.38.8.835.
3
The pharmacologic treatment of anxiety disorders: a review of progress.焦虑障碍的药物治疗:进展综述。
J Clin Psychiatry. 2010 Jul;71(7):839-54. doi: 10.4088/JCP.10r06218blu.
4
Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder.社交恐惧症、惊恐障碍和强迫症患者对安慰剂的不同反应。
Am J Psychiatry. 2004 Aug;161(8):1485-7. doi: 10.1176/appi.ajp.161.8.1485.
5
Recent advances in the understanding and treatment of anxiety disorders.焦虑症理解与治疗的最新进展
Prim Care. 2007 Sep;34(3):475-504, v-vi. doi: 10.1016/j.pop.2007.05.002.
6
[Do cognitive-behavioral group therapies in the treatment of anxiety disorders have an advantage over individual treatments?].[认知行为团体疗法在焦虑症治疗中是否比个体治疗更具优势?]
Sante Ment Que. 2004 Spring;29(1):115-26. doi: 10.7202/008825ar.
7
A survey of anxiety disorders clinics in Canadian hospitals.对加拿大医院焦虑症诊所的一项调查。
Can J Psychiatry. 1992 Apr;37(3):188-91. doi: 10.1177/070674379203700308.
8
An effectiveness study of group therapy for anxiety disorders.焦虑症团体治疗的疗效研究。
Int J Group Psychother. 2009 Apr;59(2):243-51. doi: 10.1521/ijgp.2009.59.2.243.
9
Behavioral psychotherapy for anxiety disorders.焦虑症的行为心理治疗
Psychiatr Clin North Am. 1985 Mar;8(1):25-35.
10
Guidelines on psychotropic drugs for the EC. Clinical investigation of medicinal products in the treatment of generalized anxiety disorder, panic disorder and obsessive-compulsive disorder.欧洲委员会精神药物指南。治疗广泛性焦虑症、惊恐障碍和强迫症的药品临床研究。
Eur Neuropsychopharmacol. 1995 Jun;5(2):151-5.

引用本文的文献

1
Virtual reality (VR) treatments for anxiety disorders are unambiguously successful, so why are so few therapists using it? Barriers to adoption and potential solutions.虚拟现实 (VR) 治疗焦虑症的效果明确,那么为什么很少有治疗师使用它呢?采用的障碍和潜在的解决方案。
Cogn Behav Ther. 2023 Nov;52(6):603-624. doi: 10.1080/16506073.2023.2229017. Epub 2023 Jun 28.
2
Efficacy of Psychiatric Treatment to Treat a Specific Phobia of Intravitreal Injections in a Patient with Neovascular Age-Related Macular Degeneration.精神治疗对一名患有新生血管性年龄相关性黄斑变性患者的玻璃体内注射特定恐惧症的疗效。
Case Rep Ophthalmol. 2021 Jan 13;12(1):48-56. doi: 10.1159/000510330. eCollection 2021 Jan-Apr.
3
Use of a personalised depression intervention in primary care to prevent anxiety: a secondary study of a cluster randomised trial.
在初级保健中使用个性化抑郁干预预防焦虑:一项集群随机试验的二次研究。
Br J Gen Pract. 2021 Jan 28;71(703):e95-e104. doi: 10.3399/bjgp20X714041. Print 2021.
4
The Translational Potential of Neuroimaging Genomic Analyses To Diagnosis And Treatment In The Mental Disorders.神经影像学基因组分析在精神障碍诊断与治疗中的转化潜力
Proc IEEE Inst Electr Electron Eng. 2019 May;107(5):912-927. doi: 10.1109/JPROC.2019.2913145. Epub 2019 May 9.
5
Predicting the onset of anxiety syndromes at 12 months in primary care attendees. The predictA-Spain study.预测基层医疗就诊者12个月时焦虑综合征的发病情况。PredictA-西班牙研究。
PLoS One. 2014 Sep 3;9(9):e106370. doi: 10.1371/journal.pone.0106370. eCollection 2014.
6
Emotional disclosure interventions for chronic pain: from the laboratory to the clinic.慢性疼痛的情绪表达干预:从实验室到临床。
Transl Behav Med. 2012 Mar;2(1):73-81. doi: 10.1007/s13142-011-0085-4.
7
Persistent depression and anxiety in the United States: prevalence and quality of care.美国的持续性抑郁和焦虑:患病率与护理质量
Psychiatr Serv. 2008 Dec;59(12):1391-8. doi: 10.1176/ps.2008.59.12.1391.
8
Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial.放松训练与书面情绪表露对紧张性或偏头痛的作用:一项随机对照试验
Ann Behav Med. 2008 Aug;36(1):21-32. doi: 10.1007/s12160-008-9046-7. Epub 2008 Aug 12.
9
The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.布伦达模型:将心理社会治疗与药物治疗相结合用于酒精使用障碍的治疗
J Psychiatr Pract. 2006 Mar;12(2):80-9. doi: 10.1097/00131746-200603000-00003.
10
Panic disorder.惊恐障碍
Curr Psychiatry Rep. 2001 Aug;3(4):295-301. doi: 10.1007/s11920-001-0022-1.